A group of anticardiolipin antibodies (aCL) require beta 2-glycoprotein I (beta 2GPI) to recognize their target, which might be located on endothelial cells (EC) and/or platelets. Following incubation with epithelial cells, 13 of 30 lupus sera retained EC-reactive antibodies of the IgG, IgA and IgM isotypes. Associated aCL and anti-phosphatidylethanolamine antibodies were partly absorbed on eC as well as EC. The former antibodies were more efficiently removed in the presence than in the absence of the latter. The presence of beta 2GPI in the affinity-purified aCL preparations may explain their binding to EC, as this cross-reaction was abrogated by the removal of the cofactor and restored by its re-introduction. Seventy four per cent of EC were faintly stained with polyclonal or monoclonal antibody directed to the cofactor. The beta 2GPI mediated aCL binding to EC membranes could this be influential in the development of thrombosis and/or thrombocytopenia in aCL-positive patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/096120339500400304 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The association between antiphospholipid syndrome and atrial fibrillation: a single center retrospective case-control study.
PeerJ
July 2024
Department of Cardiology, Peking University People's Hospital, Beijing, China.
Article Synopsis
- Antiphospholipid syndrome (APS) is an autoimmune disorder linked to blood clots, pregnancy issues, and low platelet counts, and this study explored its connection to atrial fibrillation (AF) at Peking University People's Hospital.
- A retrospective study compared hospitalized AF patients diagnosed by cardiologists with a control group of patients without cardiac diseases.
- Results showed that APS and the presence of specific antibodies (anticardiolipin and anti-beta-2-glycoprotein) are independent risk factors for AF, warranting further research to better understand this relationship.
The onset of autoantibodies in healthcare workers after mRNA based anti-SARS-CoV-2 vaccines: a single centre prospective follow-up study.
Autoimmunity
December 2023
Research and Innovation Department (DAIRI), "SS. Antonio e Biagio e Cesare Arrigo" Hospital, Alessandria, Italy.
Nowadays, data concerning the risk of autoimmune disease after SARS-CoV-2 (COVID-19) vaccination is controversial. The aim of this single centre prospective follow-up study was to evaluate whether healthcare workers (HCWs) vaccinated with BNT162b2 mRNA and mRNA-1273 will show a development and/or a persistence of autoantibodies, focussing on the detection of antibodies against nuclear antigens (antinuclear antibodies, ANA). We enrolled 155 HCWs, however only 108 of them received the third dose and were considered for further analysis.
View Article and Find Full Text PDFPost-viral idiopathic purpura fulminans is associated with inherited thrombophilia and anti-cardiolipin antibodies.
Front Pediatr
May 2023
Department of Pediatric Infectious Diseases and Immunology, CHU de Montpellier, University of Montpellier, Montpellier, France.
Article Synopsis
- Idiopathic purpura fulminans (IPF) is a serious coagulation disorder often linked to transient anti-protein S antibodies post-viral infection, especially after varicella, with additional complications potentially arising from anti-phospholipid antibodies and inherited thrombophilia.
- A study was conducted analyzing patients for inherited thrombophilia factors and anti-phospholipid antibodies (APL) across a French multicenter retrospective series, revealing that 28% of patients tested positive for inherited thrombophilia and 59% for APL.
- Despite the high prevalence of inherited thrombophilia and APL in patients with IPF, the study found no significant correlation between these factors and the risk of severe
Background: In this part of the study, where we determined the causes of preeclampsia and other obstetric complications, we focused on the role of tissue factor (TF) in the activation of these pathophysiological processes. Recent findings attribute a significant part of the activation of coagulation creation of autoantibodies. Once this mechanism is activated, the antibodies induce expression of tissue factor (TF, CD142) on monocytes and vascular endothelial cells.
View Article and Find Full Text PDFβ2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase.
PLoS One
August 2017
Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan.
Angiogenesis is the process of new blood vessel formation, and it plays a key role in various physiological and pathological conditions. The β2-glycoprotein I (β2-GPI) is a plasma glycoprotein with multiple biological functions, some of which remain to be elucidated. This study aimed to identify the contribution of 2-GPI on the angiogenesis induced by vascular endothelial growth factor (VEGF), a pro-angiogenic factor that may regulate endothelial remodeling, and its underlying mechanism.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!